000301726 001__ 301726
000301726 005__ 20250601020909.0
000301726 0247_ $$2doi$$a10.1002/alz.70078
000301726 0247_ $$2pmid$$apmid:40437880
000301726 0247_ $$2ISSN$$a1552-5260
000301726 0247_ $$2ISSN$$a1552-5279
000301726 0247_ $$2altmetric$$aaltmetric:177591481
000301726 037__ $$aDKFZ-2025-01118
000301726 041__ $$aEnglish
000301726 082__ $$a610
000301726 1001_ $$aFrost, Bess$$b0
000301726 245__ $$aInsights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference.
000301726 260__ $$aHoboken, NJ$$bWiley$$c2025
000301726 3367_ $$2DRIVER$$aarticle
000301726 3367_ $$2DataCite$$aOutput Types/Journal article
000301726 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1748606720_4690$$xReview Article
000301726 3367_ $$2BibTeX$$aARTICLE
000301726 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000301726 3367_ $$00$$2EndNote$$aJournal Article
000301726 520__ $$aRecent years have seen major advances in tau-associated brain disorders through interdisciplinary research spanning molecular biology, neuroimaging, clinical trials, and therapeutic development. The Tau2024 Global Conference, hosted by the Alzheimer's Association, CurePSP, and Rainwater Charitable Foundation, showcased these efforts by bringing together researchers and experts worldwide to discuss the latest advancements in tau research. The conference aimed to attract talent and funding to study tauopathies, particularly among early-career researchers, and to foster interdisciplinary alignment and collaboration around challenges in tau research. In this manuscript, we summarize proceedings of the Tau2024 Global Conference, covering a wide range of topics, including lived experiences of individuals with genetic forms of tauopathies, global perspectives on tauopathies, and molecular mechanisms, brain microenvironments, biomarker developments, clinical trials, and therapeutic approaches to tauopathies. Through international, collaborative efforts, innovative research, and a commitment to inclusivity, researchers worldwide have demonstrated transformative breakthroughs toward diagnosing, treating, and, ultimately, preventing tau-related diseases. HIGHLIGHTS: The Tau2024 Global Conference presented updates and advances in tau research. Blood-based biomarkers offer specificity and longitudinal monitoring capabilities. There are a range of targetable mechanisms in the cascade of pathogenesis. International collaboration is vital to address disparities in tauopathies.
000301726 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000301726 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000301726 650_7 $$2Other$$aAlzheimer's disease
000301726 650_7 $$2Other$$aneurodegenerative disease
000301726 650_7 $$2Other$$atau disorder
000301726 650_7 $$2Other$$atau protein
000301726 650_7 $$2Other$$atauopathies
000301726 650_7 $$2NLM Chemicals$$aBiomarkers
000301726 650_7 $$2NLM Chemicals$$atau Proteins
000301726 650_2 $$2MeSH$$aHumans
000301726 650_2 $$2MeSH$$aTauopathies: therapy
000301726 650_2 $$2MeSH$$aTauopathies: physiopathology
000301726 650_2 $$2MeSH$$aTauopathies: diagnosis
000301726 650_2 $$2MeSH$$aTauopathies: genetics
000301726 650_2 $$2MeSH$$aBiomarkers: metabolism
000301726 650_2 $$2MeSH$$aCongresses as Topic
000301726 650_2 $$2MeSH$$atau Proteins: metabolism
000301726 650_2 $$2MeSH$$aBrain: pathology
000301726 650_2 $$2MeSH$$aBrain: metabolism
000301726 7001_ $$aRowe, James B$$b1
000301726 7001_ $$aAkinyemi, Rufus O$$b2
000301726 7001_ $$aAbisambra, Jose F$$b3
000301726 7001_ $$aAshton, Nicholas J$$b4
000301726 7001_ $$0P:(DE-HGF)0$$aBrendel, Matthias$$b5
000301726 7001_ $$aBuée, Luc$$b6
000301726 7001_ $$aButler, David$$b7
000301726 7001_ $$aCarrillo, Maria C$$b8
000301726 7001_ $$aChung, Peter$$b9
000301726 7001_ $$aClelland, Claire D$$b10
000301726 7001_ $$aDeVos, Sarah L$$b11
000301726 7001_ $$aDiaz, Kristophe$$b12
000301726 7001_ $$aEdelmayer, Rebecca M$$b13
000301726 7001_ $$aElahi, Fanny M$$b14
000301726 7001_ $$aEllajosyula, Ratnavalli$$b15
000301726 7001_ $$aEwen, Colin$$b16
000301726 7001_ $$aFontana, Igor Camargo$$b17
000301726 7001_ $$aGalas, Marie-Christine$$b18
000301726 7001_ $$aHansson, Oskar$$b19
000301726 7001_ $$aHöglinger, Günter$$b20
000301726 7001_ $$aHorie, Kanta$$b21
000301726 7001_ $$aIbanez, Agustín$$b22
000301726 7001_ $$aJacobs, Linde$$b23
000301726 7001_ $$aMaina, Mahmoud B$$b24
000301726 7001_ $$aMalpetti, Maura$$b25
000301726 7001_ $$aMcDade, Eric$$b26
000301726 7001_ $$aMcEwan, Will$$b27
000301726 7001_ $$aMontoliu-Gaya, Laia$$b28
000301726 7001_ $$aMummery, Catherine J$$b29
000301726 7001_ $$aOrr, Miranda E$$b30
000301726 7001_ $$aRohrer, Jonathan D$$b31
000301726 7001_ $$aRommel, Amy$$b32
000301726 7001_ $$aSastre, Carlos$$b33
000301726 7001_ $$aSpires-Jones, Tara L$$b34
000301726 7001_ $$aTee, Boon Lead$$b35
000301726 7001_ $$aViney, Tim J$$b36
000301726 7001_ $$aWalker, Jamie M$$b37
000301726 7001_ $$aWegmann, Susanne$$b38
000301726 7001_ $$aWildsmith, Kristin$$b39
000301726 7001_ $$aYadav, Ravi$$b40
000301726 7001_ $$00000-0002-5927-7130$$aMahinrad, Simin$$b41
000301726 7001_ $$00000-0002-3846-2986$$aSexton, Claire$$b42
000301726 773__ $$0PERI:(DE-600)2201940-6$$a10.1002/alz.70078$$gVol. 21, no. 5, p. e70078$$n5$$pe70078$$tAlzheimer's and dementia$$v21$$x1552-5260$$y2025
000301726 909CO $$ooai:inrepo02.dkfz.de:301726$$pVDB
000301726 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000301726 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000301726 9141_ $$y2025
000301726 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-06$$wger
000301726 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000301726 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000301726 9201_ $$0I:(DE-He78)MU01-20160331$$kMU01$$lDKTK Koordinierungsstelle München$$x0
000301726 980__ $$ajournal
000301726 980__ $$aVDB
000301726 980__ $$aI:(DE-He78)MU01-20160331
000301726 980__ $$aUNRESTRICTED